Alteration of the polyunsaturated fatty acid (PUFA) composition of milk by dietary supplementation of cows may be beneficial to human health. However, dietary PUFAs may influence synthesis of both prostaglandins and steroid hormones. This study examined the effects of dietary PUFAs on reproductive parameters in lactating cows. Cows were fed an isoenergetic control ration (n = 8) or a diet supplemented with LinPreme (n = 7) or SoyPreme (n = 8). These proprietary feeds are derived from linseed or soybeans and contain high concentrations of linolenic acid (LNA, n-3) or linoleic acid (LA, n-6) protected PUFA, respectively. Both PUFA-supplemented diets reduced plasma progesterone, particularly in the early luteal phase, and increased the number of medium-sized (5-10 mm in diameter) follicles. The diameter of the first dominant follicle, insulin-like growth factor I (IGF-I) concentrations at oestrus and cholesterol concentrations were all higher in cows fed a diet supplemented with LA (n-6) than in cows that did not receive this supplement. In cows fed a diet supplemented with LNA (n-3), there was an increase in oestradiol during the follicular phase. Diet had no effect on non-esterified fatty acid or insulin concentrations, or on the duration of the oestrous cycle. The plasma concentration of 13,14,dihydro-15 keto PGF(2alpha) after administration of 50 iu oxytocin was unaffected by diet on day 15 and day 16 of the oestrous cycle, but showed a greater response on day 17 in the LA (n-6) supplemented group. Therefore, the PUFA content of the diet can influence both ovarian and uterine function in cows. However, further studies using larger numbers of cows are required to test whether fertility is also affected by such diets.
The relationships between insulin-like growth factor-I (IGF-I) and the fertility and milk yield of Holstein-Friesian dairy cows were investigated. The concentration of IGF-I in blood was measured weekly from one week before to 12 weeks after calving in 177 multiparous cows and at four times during this period in 142 primiparous cows; the concentration of IGF-I in milk was measured in 50 of the multiparous cows. The plasma concentrations of IGF-I were higher in the primiparous than in the multiparous animals. In the primiparous cows, high concentrations of IGF-I before calving were associated with longer calving to conception intervals. Conversely, in the multiparous cows low concentrations of IGF-I before and after calving were associated with a failure to conceive, despite repeated services. Multiparous cows with IGF-I concentrations of greater than 25 ng/ml in the week after calving were 11 times more likely to conceive to first service than those with lower concentrations. Concentrations of IGF-I greater than 50 ng/ml at first service increased the likelihood of conception five-fold. Cows with higher peak milk yields had lower plasma concentrations of IGF-I and took longer to return to ovarian cyclicity. The negative relationship between milk yield and return to cyclicity was stronger in the multiparous cows (P < 0.002) than in the primiparous cows (P < 0.04). The concentrations of IGF-I in milk followed a different pattern and were not associated with the changes in plasma IGF-I or fertility.
Dietary polyunsaturated fatty acid
Early mammalian embryo development in vitro can be enhanced by co-culture with oviductal cells and by the addition of insulin-like growth factors (IGFs). This study examined the expression patterns of the oviductal IGF system in cattle in relation to the number of days after oestrus and the presence or absence of embryos. Oviducts were collected from: (i) 66 nulliparous heifers on day 3, day 6 or day 16 after insemination and from (ii) ten non-pregnant, lactating cows on day 0 or day 1 of the oestrous cycle. Oviducts were coiled, frozen whole and sectioned for in situ hybridization. Expression patterns of mRNAs encoding IGF-I, IGF-II, type 1 IGF receptor (IGF-1R), and the IFG binding proteins (IGFBP)-1, -3 and -5 were determined from autoradiographs. Separate measurements were made for the mucosa and muscle layers of the infundibulum, ampulla and isthmus. None of the parameters measured differed between heifers with or without the presence of an embryo. mRNAs encoding IGF-I and IGF-1R were present in the mucosa and muscle of all three oviductal regions, and the highest value of IGF-I mRNA was measured in heifers on day 3. IGF-II mRNA was expressed predominantly in the muscle wall. IGFBP-1 mRNA was not detectable, whereas mRNAs encoding IGFBP-3 and -5 were expressed in both the muscle and mucosa. IGFBP-3 expression was higher in cows on day 0 and day 1 of the oestrous cycle than in heifers on day 3, day 6 and day 16 after insemination. A peak of IGFBP-5 expression was reached on day 6. Locally or systemically produced IGFs, regulated by IGFBPs, may act directly on the embryo or indirectly via modulation of oviductal secretions and muscular activity to influence the success of early embryo development.
Bovine tuberculosis is a chronic bacterial disease caused by Mycobacterium bovis. It can be transmitted to humans through direct contact with infected cattle or consumption of unpasteurized milk and milk products. The current study was performed to assess whether raw milk produced in three large scale dairy farms in Central Province of Sri Lanka contain any M. bovis. Raw milk samples were collected from 330 cows representing 230 single intradermal comparative cervical tuberculin test reactors and 100 none-reactors. All milk samples were cultured on Lowenstein Jensen medium with/ without sodium pyruvate for the isolation of Mycobacterium spp., and slopes were observed for the occurrence of growth daily for the first week and then at weekly intervals for 8 weeks. Direct Polymerase Chain Reaction (PCR) was performed simultaneously on all milk samples to detect M. bovis after extracting DNA with a commercial kit. The minimum detection level of M. bovis for PCR in milk was 200 CFU/mL. Only two milk samples from reactive cows were positive for acid fast bacilli. However, their cultures were confirmed as non-tuberculous mycobacteria by PCR. Consequently, all milk samples were confirmed negative for M. bovis according to direct PCR. It was concluded that the milk samples from three large scale dairy farms in Central Province of Sri Lanka did not contain M. bovis.
Achieving adequate fertility is essential in any dairy unit, but is compromised by genetic selection for increased yield. Selection has altered the somatotrophic axis and resulted in cows which mobilise more body tissue for milk production in early lactation, thus prolonging both the depth and duration of the post partum negative energy balance. Poor energy status is reflected in altered metabolic parameters including raised urea and decreased insulin-like growth factor-I (IGF-I) and insulin concentrations, which adversely affect ovarian cyclicity and early embryo survival. Attempts to optimise the diet in terms of energy and protein content have generally been aimed at increasing milk production further rather than improving fertility. Advances in biosensor technology now provide us with the opportunity to monitor production, fertility and health parameters of each cow. Integration of this information should improve the timing for inseminations and could assist in selecting diets more suited to the needs of the individual cow. Genetic selection may in future be used to produce cows optimised for a particular type of management system. In both cases we need a greater understanding of the rules governing nutrient partitioning at different stages of the cows' life cycle to ensure that diets selected are cost effective and achieve an appropriate balance in promoting production, reproduction and health.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
334 Leonard St
Brooklyn, NY 11211
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.